#pharmaceutical-companies

#pharmaceutical-companies

An AI researcher at Stanford University has drafted a paper showing that OpenAI's new chatbot, ChatGPT, has an aptitude for corporate lobbying.In his paper, John J. Nay argued that as language models continue to improve, so will their performance on corporate lobbying tasks.It suggests a future where corporate lobbyists, which make up the largest group of lobbyists on the Hill and spend billions of dollars a year influencing political decision-makers, will be able to automate the process of drafting legislation and sending letters to the government.

Ministers have systematically dismantled critical vaccine plans drawn up during the Covid crisis and left the country recklessly exposed to another pandemic, one of the most senior figures shaping Britain's scientific response to the virus has warned.In a damning verdict that comes just days before the official Covid inquiry starts publicly examining Britain's preparedness for pandemics, Dr Clive Dix, the former chairman of the UK's vaccine taskforce, said the abandonment of schemes developed during Covid now left Britain fraught with danger.

The company claims that the plan to allow Medicare to negotiate drug prices violates the First and Fifth Amendments.A Merck flag flies in front of the company's building on October 2, 2013, in Summit, New Jersey.Kena Betancur / Getty Images Merck announced on Tuesday that it is suing the government over a recently approved plan to allow Medicare to negotiate prescription drug prices, aiming to stop one of the nation's first efforts to take a small step toward lowering sky-high drug prices in the U.S.
The lawsuit, filed in a federal court in Washington on Tuesday, claims that the plan is unconstitutional and calls it a "sham" and "tantamount to extortion."

Appeal comes amid concern strict intellectual property rules hamper the production of affordable vaccines and medicines.Hiroshima, Japan Scientists have called on the Group of Seven to take urgent action to tackle the world's lack of preparedness for the next pandemic, warning that developing countries continue to lack access to life-saving treatments and vaccines.

Welcome to the HBR Video Quick Take.I'm Todd Pruzan, senior editor for Research and Special Projects at Harvard Business Review.A decentralized clinical trial, or DCT, is a method of conducting clinical trials in which part or all of the trial happens outside a traditional physical clinic or trial site.

Moderna's mRNA-based vaccine against RSV (respiratory syncytial (sin-SISH-uhl) virus) was effective at preventing disease in older adults, according to preliminary, top-line results of an ongoing phase III clinical trial the company announced Tuesday.Moderna said it will now seek regulatory approval for the vaccine in the first half of this year.

The UK has been warned it is haemorrhaging moral authority after tumbling into second-last place in the league table for the global fight against Covid-19.Only India ranked behind Britain in the analysis of G20 states conducted by charity Christian Aid and the People's Vaccine Alliance.But the campaigners said none of the group  made up of the world's 19 most powerful national economies and the EU  was doing enough to fight the pandemic in poorer countries around the globe.

Dr. Steven Deeks, an infectious disease specialist at UCSF who has extensively researched long COVID, argues that clinical trials for possible treatments should have started months ago."Based on the fact there's anecdotes of people getting better with antiviral therapy, yes, it's an absolute urgency right now to study, in a controlled manner, all of the antiviral therapies that we have available," he said.

Shipping containers are reshuffled and stored at a commercial port in Vladivostok, Russia, on Wednesday.(Tatiana Meel/Reuters)Russia's Industry and Trade Ministry said Wednesday that it had taken steps to establish domestic production of generic forms of Viagra, the erectile dysfunction remedy, after the U.S. manufacturer of the drug halted supplies.

The German government said Tuesday that it will allow health insurance companies to pay more for pediatric medications that are in short supply in the country.Germans have scrambled to find basic drugs such as painkillers in recent weeks amid delivery bottlenecks and higher-than-usual demand.Health Minister Karl Lauterbach said insurers that form the backbone of the German public health system will be able to pay 50% more than the legally set price for patent-free medicines.

A pair of community health centers - Heritage Health and Housing in Harlem and Evergreen Health in Buffalo - filed a lawsuit late last week against the New York State Department of Health to block the upcoming launch of a new prescription drug plan for Medicaid members, known as NYRx.It's part of a final attempt by several stakeholders to derail the plan, which takes effect this Saturday.

Just before President Joe Biden's visit to Florida on Thursday, one of the state's Republican senators, Rick Scott, repeated a false claim about Biden and Medicare a claim that was debunked by multiple news outlets when Scott and a Scott-chaired Republican organization uttered it during the 2022 midterm campaign.

"This year, the Federal Circuit will decide whether a judge-made-doctrine can truncate a legislative grant of patent term adjustment....In doing so it could craft a bright-line rule that a judge-made doctrine cannot cut off a statutorily authorized time extension."Patent Term Adjustment (PTA) was designed to serve an important purpose - to compensate patentees for time lost during examination due to U.S. Patent and Trademark Office (USPTO) delays.